100 related articles for article (PubMed ID: 26218743)
1. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
Shi Q; Zhang L; Liu M; Zhang X; Zhang X; Xu X; Chen S; Li X; Zhang J
Biomaterials; 2015 Oct; 67():169-82. PubMed ID: 26218743
[TBL] [Abstract][Full Text] [Related]
2. Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma.
Stepanović A; Terzić Jovanović N; Korać A; Zlatović M; Nikolić I; Opsenica I; Pešić M
Biomed Pharmacother; 2024 May; 174():116496. PubMed ID: 38537581
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Multidrug Resistance in Cancer Chemotherapy.
Bukowski K; Kciuk M; Kontek R
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370233
[TBL] [Abstract][Full Text] [Related]
4. pH-Responsive Lipid Nanocapsules: A Promising Strategy for Improved Resistant Melanoma Cell Internalization.
Pautu V; Lepeltier E; Mellinger A; Riou J; Debuigne A; Jérôme C; Clere N; Passirani C
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922267
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for anticancer and antimicrobial treatment: an overview.
Kulshrestha S; Khan AU
IET Nanobiotechnol; 2018 Dec; 12(8):1009-1017. PubMed ID: 30964006
[TBL] [Abstract][Full Text] [Related]
6. Multidrug Resistance in Cancer Circumvented Using a Cytosolic Drug Reservoir.
Fan L; Zhang S; Zhang C; Yin C; Chu Z; Song C; Lin G; Li Q
Adv Sci (Weinh); 2018 Feb; 5(2):1700289. PubMed ID: 29619295
[TBL] [Abstract][Full Text] [Related]
7. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.
Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS
Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744
[TBL] [Abstract][Full Text] [Related]
8. Supramolecular host-guest nanosystems for overcoming cancer drug resistance.
Wu S; Yan M; Liang M; Yang W; Chen J; Zhou J
Cancer Drug Resist; 2023; 6(4):805-827. PubMed ID: 38263983
[TBL] [Abstract][Full Text] [Related]
9. Nanodelivery systems: An efficient and target-specific approach for drug-resistant cancers.
Ashique S; Garg A; Hussain A; Farid A; Kumar P; Taghizadeh-Hesary F
Cancer Med; 2023 Sep; 12(18):18797-18825. PubMed ID: 37668041
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnological approaches for counteracting multidrug resistance in cancer.
Martinelli C; Biglietti M
Cancer Drug Resist; 2020; 3(4):1003-1020. PubMed ID: 35582219
[TBL] [Abstract][Full Text] [Related]
11. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.
Chen D; Ge S; Zuo L; Wang S; Liu M; Li S
Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance.
Zhang X; Ren X; Tang J; Wang J; Zhang X; He P; Yao C; Bian W; Sun L
Drug Deliv; 2020 Dec; 27(1):825-835. PubMed ID: 32489129
[TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route.
Zhou X; Ling K; Liu M; Zhang X; Ding J; Dong Y; Liang Z; Li J; Zhang J
Theranostics; 2019; 9(22):6568-6586. PubMed ID: 31588236
[TBL] [Abstract][Full Text] [Related]
14. Integrating Stimuli-Responsive Properties in Host-Guest Supramolecular Drug Delivery Systems.
Braegelman AS; Webber MJ
Theranostics; 2019; 9(11):3017-3040. PubMed ID: 31244940
[TBL] [Abstract][Full Text] [Related]
15. Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.
Zhou L; Wang H; Li Y
Theranostics; 2018; 8(4):1059-1074. PubMed ID: 29463999
[TBL] [Abstract][Full Text] [Related]
16. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
Zhou C; Cheng H; Qin W; Zhang Y; Xiong H; Yang J; Huang H; Wang Y; Chen XZ; Tang J
Oncotarget; 2017 Apr; 8(17):27915-27928. PubMed ID: 28427190
[TBL] [Abstract][Full Text] [Related]
17. Reducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel Nanoconjugates.
Li F; Zhou X; Zhou H; Jia J; Li L; Zhai S; Yan B
PLoS One; 2016; 11(7):e0160042. PubMed ID: 27467397
[TBL] [Abstract][Full Text] [Related]
18. A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.
Dan Z; Cao H; He X; Zhang Z; Zou L; Zeng L; Xu Y; Yin Q; Xu M; Zhong D; Yu H; Shen Q; Zhang P; Li Y
Theranostics; 2016; 6(3):435-45. PubMed ID: 26909117
[TBL] [Abstract][Full Text] [Related]
19. A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.
Zhou Z; Han Z; Lu ZR
Biomaterials; 2016 Apr; 85():168-79. PubMed ID: 26874280
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
